156 studies found for:    Open Studies | "Dermatitis"
Show Display Options
Rank Status Study
21 Recruiting Registry for the Atopic Dermatitis Research Network
Conditions: Atopic Dermatitis;   Eczema Herpeticum
Intervention:
22 Unknown  Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis
Condition: Allergic Contact Dermatitis
Interventions: Drug: MRX-6;   Drug: Steroid
23 Unknown  Vulvar Contact Dermatitis Resulting From Urine Incontinence
Conditions: Urinary Incontinence;   Vulvar Pruritus;   Vulvar Contact Dermatitis
Intervention: Other: Questionnaires, gynecological exam , vaginal smear, and measurement of urine leakage
24 Not yet recruiting Effect of Holly Mangrove Shower Gel in Atopic Dermatitis Patients
Condition: Atopic Dermatitis
Interventions: Other: Placebo shower gel;   Other: Holly Mangrove Shower Gel
25 Recruiting Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD)
Condition: Atopic Dermatitis
Intervention: Biological: FURESTEM-AD Inj.
26 Unknown  Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
Condition: Seborrheic Dermatitis
Intervention: Biological: Petroleum Jelly
27 Not yet recruiting Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients
Conditions: Atopic Dermatitis;   Eczema
Intervention: Biological: Moisturizer with each subject's own antimicrobial bacteria
28 Unknown  Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
Condition: Atopic Dermatitis
Intervention: Drug: tacrolimus ointment
29 Recruiting A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: CT327 ointment;   Drug: placebo
30 Recruiting A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis
Condition: Dermatitis, Atopic
Interventions: Drug: Ustekinumab;   Drug: Placebo;   Other: Concomitant topical medications for atopic dermatitis
31 Recruiting ADRN Barrier/Immunoprofiling Exploratory Pilot Study
Conditions: Dermatitis;   Dermatitis, Atopic
Intervention:
32 Unknown  Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis
Condition: Dermatitis Herpetiformis
Intervention: Drug: Dapsone gel, 5%
33 Recruiting Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis
Condition: Skin Alterations Associated With Atopic Dermatitis
Interventions: Drug: Sertaconazole 2% cream;   Drug: Placebo
34 Recruiting Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan® Regimen
Condition: Atopic Dermatitis
Interventions: Other: Ceradan Cream;   Other: Ceradan Wash
35 Recruiting Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis
Condition: Treatment-resistant Pruritus Associated With Atopic Dermatitis
Interventions: Drug: VLY-686;   Drug: Placebo
36 Recruiting Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis
Condition: Dermatitis, Atopic
Intervention: Drug: AN2728 Topical Ointment, 2%
37 Recruiting Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis
Condition: Dermatitis, Atopic
Intervention: Drug: AN2728 Topical Ointment, 2%
38 Not yet recruiting Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment Adherence
Condition: Atopic Dermatitis
Intervention:
39 Recruiting Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)
Condition: Dermatitis, Atopic
Interventions: Drug: Tofacitinib ointment 20mg/g;   Drug: Placebo ointment (Vehicle)
40 Recruiting A Randomized Placebo-controlled Study to Determine the Safety, Tolerability, Pharmacodynamics and Clinical Efficacy of ILV-094 (an IL-22 Antibody) Administered Intravenously to Subjects With Atopic Dermatitis (AD)
Condition: Atopic Dermatitis
Interventions: Drug: ILV-094;   Drug: Placebo Comparator

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years